首页 > 最新文献

Australian Health Review最新文献

英文 中文
Evaluating an implementation of the Australian National Guidelines for the On-Screen Display of Discharge Summaries. 评估澳大利亚出院总结屏幕显示国家指南的实施情况。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 DOI: 10.1071/AH22248
Masarrat Mahera, Hamish Rodda, Nick Monypenny, Paul Wembridge

Objective The objective of this study was to evaluate changes in the inclusion of pertinent information on electronic discharge summaries (eDS) after implementation of a revised template and electronic medical record (EMR) workflow. Methods A retrospective medical record audit of eDS at three metropolitan hospitals was undertaken for adult inpatient encounters in June 2021 (pre-intervention, n  = 100) and June 2022 (post-intervention, n  = 100). The eDS were evaluated against 16 components listed in the Australian National Guidelines for the On-Screen Display of Discharge Summaries. Nine components were further broken down to between two and 11 sub-components. Sub-analysis compared a hospital with full EMR to pooled results from hospitals with hybrid EMRs. Components and sub-components were evaluated for inclusion only; accuracy or relevance of the information was not assessed. Results Inclusion of three out of 16 components (presentation details: 47% vs 62%, problems and diagnosis: 61% vs 86% and recipient details: 82% vs 93%) and eight out of 36 sub-components (discharge destination, principal diagnosis, history of presenting complaint, infection risk, pressure injury, screening and/or diagnosis of delirium and GP phone number and address) was higher in the post-intervention group (all P  < 0.05). Reduced eDS information inclusion in the post-intervention group was observed for discharge date and falls risk only (both P  < 0.05). Reporting of falls history decreased at the hospital with full EMR (71% vs 20% P  < 0.001) but not at hospitals utilising hybrid EMRs (24% vs 30% P  = 0.5). Conclusion The intervention was associated with improved inclusion of pertinent information as described in the Australian National Guidelines for the On-Screen Display of Discharge Summaries.

目的本研究的目的是评估在实施修订后的模板和电子病历(EMR)工作流程后,电子出院摘要(eDS)中相关信息的纳入变化。方法对2021年6月三家大都市医院的成人住院患者的eDS进行回顾性医疗记录审计(干预前 = 100)和2022年6月(干预后,n = 100)。根据《澳大利亚出院总结屏幕显示指南》中列出的16种成分对eDS进行评估。9个组成部分被进一步分解为2至11个子组成部分。子分析将一家拥有完整电子病历的医院与拥有混合电子病历医院的汇总结果进行了比较。仅评估了成分和子成分是否包含;未评估信息的准确性或相关性。结果16个成分中的3个成分(表现细节:47%对62%,问题和诊断:61%对86%,接受者细节:82%对93%)和36个子成分中的8个成分(出院目的地、主要诊断、表现主诉史、感染风险、压力损伤、谵妄筛查和/或诊断以及全科医生电话号码和地址)在干预后组(P
{"title":"Evaluating an implementation of the Australian National Guidelines for the On-Screen Display of Discharge Summaries.","authors":"Masarrat Mahera,&nbsp;Hamish Rodda,&nbsp;Nick Monypenny,&nbsp;Paul Wembridge","doi":"10.1071/AH22248","DOIUrl":"10.1071/AH22248","url":null,"abstract":"<p><p>Objective The objective of this study was to evaluate changes in the inclusion of pertinent information on electronic discharge summaries (eDS) after implementation of a revised template and electronic medical record (EMR) workflow. Methods A retrospective medical record audit of eDS at three metropolitan hospitals was undertaken for adult inpatient encounters in June 2021 (pre-intervention, n  = 100) and June 2022 (post-intervention, n  = 100). The eDS were evaluated against 16 components listed in the Australian National Guidelines for the On-Screen Display of Discharge Summaries. Nine components were further broken down to between two and 11 sub-components. Sub-analysis compared a hospital with full EMR to pooled results from hospitals with hybrid EMRs. Components and sub-components were evaluated for inclusion only; accuracy or relevance of the information was not assessed. Results Inclusion of three out of 16 components (presentation details: 47% vs 62%, problems and diagnosis: 61% vs 86% and recipient details: 82% vs 93%) and eight out of 36 sub-components (discharge destination, principal diagnosis, history of presenting complaint, infection risk, pressure injury, screening and/or diagnosis of delirium and GP phone number and address) was higher in the post-intervention group (all P  < 0.05). Reduced eDS information inclusion in the post-intervention group was observed for discharge date and falls risk only (both P  < 0.05). Reporting of falls history decreased at the hospital with full EMR (71% vs 20% P  < 0.001) but not at hospitals utilising hybrid EMRs (24% vs 30% P  = 0.5). Conclusion The intervention was associated with improved inclusion of pertinent information as described in the Australian National Guidelines for the On-Screen Display of Discharge Summaries.</p>","PeriodicalId":55425,"journal":{"name":"Australian Health Review","volume":" ","pages":"535-544"},"PeriodicalIF":1.8,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9945310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Government-supported clinical knowledge and information resource portals are key to ensuring quality, safe health care and evidence-based practice - the Australian context. 政府支持的临床知识和信息资源门户网站是确保澳大利亚医疗质量、安全和循证实践的关键。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 DOI: 10.1071/AH23101
Gemma Siemensma, Alice Anderson, Cassandra Gorton

Objective The aim of this study was to describe Australia's government-supported clinical knowledge and information resource portals and their alignment with government policies for digital health within an Australian context, and to clarify the role of hospital libraries in the public health system as an adjunct to state and territory portals. Methods Government-supported clinical resource portals in Australian states and territories were examined and benchmarked. A comprehensive search of Australian state, territory, and federal government websites was conducted for strategies, policies, and projects relating to medical research, digital health, and health workforce education. These documents were screened for reference to clinical knowledge and information resource portals, clinical decision support tools, hospital libraries, or educational resources for the health workforce. Additionally, information was derived from relevant published Australian studies to provide context and additional information about access to evidence in public hospitals. Results Clinical resource portals are a vital part of evidence-based health care in Australia; however, there are inconsistencies in these portals due to differences in policy, funding, and strategy between Australia's states and territories. Libraries in the healthcare sector play a key role in ensuring centralised clinical knowledge and information resource portals are easily available to clinicians, and in building on the initial portal collection, curate bespoke library collections for their individual organisations. Conclusion This investigation highlights the importance of government-supported clinical knowledge and information resource portals and the role they play in the provision of safe, quality, evidence-based health care. These portals, in conjunction with hospital library activities, are an integral part of the clinical governance framework.

目的本研究旨在描述澳大利亚政府支持的临床知识和信息资源门户网站及其与澳大利亚政府数字健康政策的一致性,并阐明医院图书馆作为州和地区门户网站的附属机构在公共卫生系统中的作用。方法对澳大利亚各州和地区政府支持的临床资源门户网站进行检查和基准测试。对澳大利亚各州、地区和联邦政府网站进行了全面搜索,以了解与医学研究、数字健康和卫生劳动力教育有关的战略、政策和项目。对这些文件进行了筛选,以参考临床知识和信息资源门户网站、临床决策支持工具、医院图书馆或卫生工作者的教育资源。此外,信息来源于澳大利亚已发表的相关研究,以提供有关公立医院获取证据的背景和其他信息。结果临床资源门户网站是澳大利亚循证医疗的重要组成部分;然而,由于澳大利亚各州和地区在政策、资金和战略方面的差异,这些门户网站存在不一致之处。医疗保健部门的图书馆在确保临床医生能够轻松获得集中的临床知识和信息资源门户方面发挥着关键作用,并在最初的门户收藏的基础上,为其各个组织策划定制的图书馆收藏。结论本调查强调了政府支持的临床知识和信息资源门户的重要性,以及它们在提供安全、高质量、循证医疗保健方面发挥的作用。这些门户网站与医院图书馆活动相结合,是临床治理框架的组成部分。
{"title":"Government-supported clinical knowledge and information resource portals are key to ensuring quality, safe health care and evidence-based practice - the Australian context.","authors":"Gemma Siemensma,&nbsp;Alice Anderson,&nbsp;Cassandra Gorton","doi":"10.1071/AH23101","DOIUrl":"10.1071/AH23101","url":null,"abstract":"<p><p>Objective The aim of this study was to describe Australia's government-supported clinical knowledge and information resource portals and their alignment with government policies for digital health within an Australian context, and to clarify the role of hospital libraries in the public health system as an adjunct to state and territory portals. Methods Government-supported clinical resource portals in Australian states and territories were examined and benchmarked. A comprehensive search of Australian state, territory, and federal government websites was conducted for strategies, policies, and projects relating to medical research, digital health, and health workforce education. These documents were screened for reference to clinical knowledge and information resource portals, clinical decision support tools, hospital libraries, or educational resources for the health workforce. Additionally, information was derived from relevant published Australian studies to provide context and additional information about access to evidence in public hospitals. Results Clinical resource portals are a vital part of evidence-based health care in Australia; however, there are inconsistencies in these portals due to differences in policy, funding, and strategy between Australia's states and territories. Libraries in the healthcare sector play a key role in ensuring centralised clinical knowledge and information resource portals are easily available to clinicians, and in building on the initial portal collection, curate bespoke library collections for their individual organisations. Conclusion This investigation highlights the importance of government-supported clinical knowledge and information resource portals and the role they play in the provision of safe, quality, evidence-based health care. These portals, in conjunction with hospital library activities, are an integral part of the clinical governance framework.</p>","PeriodicalId":55425,"journal":{"name":"Australian Health Review","volume":" ","pages":"596-601"},"PeriodicalIF":1.8,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10170421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical governance implications of a Victorian coronial finding regarding contrast-related anaphylaxis for health services and private providers of radiology services. 维多利亚州一项关于造影剂相关过敏反应的验尸结果对卫生服务和私人放射服务提供者的临床治理影响。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 DOI: 10.1071/AH23135
Belle Lu, Anne-Maree Kelly, Tina Cockburn

What is known about the topic? Anaphylaxis is a rare but inherent risk of treatments and investigational agents. What does this paper add? Using a recent coronial finding in Victoria, this letter explores clinical governance responsibilities of health services and private providers of radiology services with respect to anaphylaxis recognition and management. What are the implications for practitioners? There is a strong case for health service and corporate governance teams (for stand-alone clinics) to ensure that all staff have recent, adequate training to recognise and initiate treatment of anaphylaxis. Reliance on an ambulance response is not enough.

关于这个话题,大家知道些什么?过敏反应是治疗和研究药物的一种罕见但固有的风险。这篇论文增加了什么?这封信利用维多利亚州最近的一项死因调查结果,探讨了卫生服务和私人放射服务提供者在过敏反应识别和管理方面的临床治理责任。对从业者有什么影响?卫生服务和公司治理团队(对于独立诊所)有充分的理由确保所有员工都接受了最近的充分培训,以识别和开始过敏反应的治疗。仅仅依靠救护车的反应是不够的。
{"title":"Clinical governance implications of a Victorian coronial finding regarding contrast-related anaphylaxis for health services and private providers of radiology services.","authors":"Belle Lu,&nbsp;Anne-Maree Kelly,&nbsp;Tina Cockburn","doi":"10.1071/AH23135","DOIUrl":"10.1071/AH23135","url":null,"abstract":"<p><p>What is known about the topic? Anaphylaxis is a rare but inherent risk of treatments and investigational agents. What does this paper add? Using a recent coronial finding in Victoria, this letter explores clinical governance responsibilities of health services and private providers of radiology services with respect to anaphylaxis recognition and management. What are the implications for practitioners? There is a strong case for health service and corporate governance teams (for stand-alone clinics) to ensure that all staff have recent, adequate training to recognise and initiate treatment of anaphylaxis. Reliance on an ambulance response is not enough.</p>","PeriodicalId":55425,"journal":{"name":"Australian Health Review","volume":" ","pages":"629-630"},"PeriodicalIF":1.8,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9858725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
External validation of the Health Care Homes hospital admission risk stratification tool in the Aboriginal Australian population of the Northern Territory. 在北领地的澳大利亚原住民中,对保健院住院风险分层工具进行外部验证。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 DOI: 10.1071/AH23017
Laura Goddard, Emma Field, Judy Moran, Julie Franzon, Yuejen Zhao, Paul Burgess

Objective This study aimed to externally validate the Commonwealth's Health Care Homes (HCH) algorithm for Aboriginal Australians living in the Northern Territory (NT). Methods A retrospective cohort study design using linked primary health care (PHC) and hospital data was used to analyse the performance of the HCH algorithm in predicting the risk of hospitalisation for the NT study population. The study population consisted of Aboriginal Australians residing in the NT who have visited a PHC clinic at one of the 54 NT Government clinics at least once between 1 January 2013 and 31 December 2017. Predictors of hospitalisation included demographics, patient observations, medications, diagnoses, pathology results and previous hospitalisation. Results There were a total of 3256 (28.5%) emergency attendances or preventable hospitalisations during the study period. The HCH algorithm had an area under the receiver operating characteristic curve (AUC) of 0.58 for the NT remote Aboriginal population, compared with 0.66 in the Victorian cohort. A refitted model including 'previous hospitalisation' had an AUC of 0.72, demonstrating better discrimination than the HCH algorithm. Calibration was also improved in the refitted model, with an intercept of 0.00 and a slope of 1.00, compared with an intercept of 1.29 and a slope of 0.55 in the HCH algorithm. Conclusion The HCH algorithm performed poorly on the NT cohort compared with the Victorian cohort, due to differences in population demographics and burden of disease. A population-specific hospitalisation risk algorithm is required for the NT.

目的本研究旨在对居住在北领地(NT)的澳大利亚原住民的联邦医疗保健院(HCH)算法进行外部验证。方法使用关联初级卫生保健(PHC)和医院数据进行回顾性队列研究设计,分析HCH算法在预测NT研究人群住院风险方面的性能。研究人群包括居住在新界的澳大利亚原住民,他们在2013年1月1日至2017年12月31日期间至少去过54家新界政府诊所之一的初级保健诊所一次。住院的预测因素包括人口统计、患者观察、药物、诊断、病理结果和既往住院情况。结果在研究期间,共有3256例(28.5%)急诊就诊或可预防住院。对于NT偏远原住民,HCH算法的受试者工作特征曲线下面积(AUC)为0.58,而在维多利亚州队列中为0.66。一个包括“先前住院”在内的改装模型的AUC为0.72,显示出比HCH算法更好的辨别力。改装后的模型的校准也得到了改进,截距为0.00,斜率为1.00,而六氯环己烷算法的截距为1.29,斜率为0.55。结论与维多利亚州队列相比,由于人口统计学和疾病负担的差异,HCH算法在NT队列中的表现较差。NT需要特定人群的住院风险算法。
{"title":"External validation of the Health Care Homes hospital admission risk stratification tool in the Aboriginal Australian population of the Northern Territory.","authors":"Laura Goddard,&nbsp;Emma Field,&nbsp;Judy Moran,&nbsp;Julie Franzon,&nbsp;Yuejen Zhao,&nbsp;Paul Burgess","doi":"10.1071/AH23017","DOIUrl":"10.1071/AH23017","url":null,"abstract":"<p><p>Objective This study aimed to externally validate the Commonwealth's Health Care Homes (HCH) algorithm for Aboriginal Australians living in the Northern Territory (NT). Methods A retrospective cohort study design using linked primary health care (PHC) and hospital data was used to analyse the performance of the HCH algorithm in predicting the risk of hospitalisation for the NT study population. The study population consisted of Aboriginal Australians residing in the NT who have visited a PHC clinic at one of the 54 NT Government clinics at least once between 1 January 2013 and 31 December 2017. Predictors of hospitalisation included demographics, patient observations, medications, diagnoses, pathology results and previous hospitalisation. Results There were a total of 3256 (28.5%) emergency attendances or preventable hospitalisations during the study period. The HCH algorithm had an area under the receiver operating characteristic curve (AUC) of 0.58 for the NT remote Aboriginal population, compared with 0.66 in the Victorian cohort. A refitted model including 'previous hospitalisation' had an AUC of 0.72, demonstrating better discrimination than the HCH algorithm. Calibration was also improved in the refitted model, with an intercept of 0.00 and a slope of 1.00, compared with an intercept of 1.29 and a slope of 0.55 in the HCH algorithm. Conclusion The HCH algorithm performed poorly on the NT cohort compared with the Victorian cohort, due to differences in population demographics and burden of disease. A population-specific hospitalisation risk algorithm is required for the NT.</p>","PeriodicalId":55425,"journal":{"name":"Australian Health Review","volume":" ","pages":"521-534"},"PeriodicalIF":1.8,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10215535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Clinical Trials Assistance Pilot: reducing the financial burden of cancer clinical trials for patients in regional New South Wales. 临床试验援助试点:减轻癌症临床试验对新南威尔士州患者的财政负担。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 DOI: 10.1071/AH22249
Pareoranga Luiten-Apirana, Monica Gendi, Jai Bernard, Zhicheng Li, Rhiannon Edge, Bradley Gellert, Annie Miller, Maria Mury, Niki Sansey, Lindsey Jasicki, Sean Stolp

Objective This study investigated whether the provision of financial assistance to patients living in regional New South Wales influenced patients' decisions to participate in a cancer clinical trial (cancer treatment or supportive care) and resulted in improved psychosocial outcomes. Methods Administrative data were collected from participants, including demographics, travel distances and the value of financial support provided. Qualitative interviews were then conducted with a subset of consenting patients who received financial assistance for a clinical trial. Results Sixty-four patients with cancer received financial support for a clinical trial, 27 (42%) of whom were interviewed. Participants whose distance to a trial site was over 400 km received almost three times as much financial support (M  = A$3194.20, s.d. = A$1597.60) as participants whose distance to a trial site was between 50 and 100 km (M  = A$1116.29, s.d. = $A1311.23). Half of participants indicated that receiving financial assistance influenced their decision to participate in a clinical trial, and most indicated the support alleviated the financial burden of clinical trial participation. Conclusions The provision of financial assistance to patients living in regional areas may reduce inequities in cancer clinical trial participation and improve psychosocial outcomes.

目的本研究调查向生活在新南威尔士州地区的患者提供经济援助是否影响患者参与癌症临床试验(癌症治疗或支持性护理)的决定,并导致心理社会结果的改善。方法收集参与者的行政数据,包括人口统计、旅行距离和所提供的财政支持的价值。然后对接受临床试验经济援助的同意患者进行定性访谈。结果64名癌症患者接受了临床试验的经济支持,其中27人(42%)接受了访谈。到试验地点的距离超过400的参与者 km获得了几乎三倍的财政支持(M = 3194.20澳元,s.d。 = 1597.60澳元)作为与试验地点距离在50至100之间的参与者 公里(M = 1116.29澳元,s.d。 = $A1311.23)。一半的参与者表示,接受经济援助会影响他们参加临床试验的决定,大多数人表示,这种支持减轻了参与临床试验的经济负担。结论向居住在地区的患者提供经济援助可以减少癌症临床试验参与的不公平现象,改善心理社会结果。
{"title":"The Clinical Trials Assistance Pilot: reducing the financial burden of cancer clinical trials for patients in regional New South Wales.","authors":"Pareoranga Luiten-Apirana,&nbsp;Monica Gendi,&nbsp;Jai Bernard,&nbsp;Zhicheng Li,&nbsp;Rhiannon Edge,&nbsp;Bradley Gellert,&nbsp;Annie Miller,&nbsp;Maria Mury,&nbsp;Niki Sansey,&nbsp;Lindsey Jasicki,&nbsp;Sean Stolp","doi":"10.1071/AH22249","DOIUrl":"10.1071/AH22249","url":null,"abstract":"<p><p>Objective This study investigated whether the provision of financial assistance to patients living in regional New South Wales influenced patients' decisions to participate in a cancer clinical trial (cancer treatment or supportive care) and resulted in improved psychosocial outcomes. Methods Administrative data were collected from participants, including demographics, travel distances and the value of financial support provided. Qualitative interviews were then conducted with a subset of consenting patients who received financial assistance for a clinical trial. Results Sixty-four patients with cancer received financial support for a clinical trial, 27 (42%) of whom were interviewed. Participants whose distance to a trial site was over 400 km received almost three times as much financial support (M  = A$3194.20, s.d. = A$1597.60) as participants whose distance to a trial site was between 50 and 100 km (M  = A$1116.29, s.d. = $A1311.23). Half of participants indicated that receiving financial assistance influenced their decision to participate in a clinical trial, and most indicated the support alleviated the financial burden of clinical trial participation. Conclusions The provision of financial assistance to patients living in regional areas may reduce inequities in cancer clinical trial participation and improve psychosocial outcomes.</p>","PeriodicalId":55425,"journal":{"name":"Australian Health Review","volume":" ","pages":"607-613"},"PeriodicalIF":1.8,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10396053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obstacles in establishing a national disease registry in Australia: lessons from the development of the CHAANZ Congenital Heart Disease Registry. 在澳大利亚建立国家疾病登记的障碍:CHAANZ先天性心脏病登记发展的经验教训。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-08-01 DOI: 10.1071/AH23063
Larissa K Lloyd, Reeja Nasir, Calum Nicholson, Geoff Strange, David S Celermajer

Objectives To provide insights into the obstacles which pose challenges to the set-up of any National Registry in Australia. Methods An analysis of our experience in executing a Multi-Institutional Agreement (MIA) and obtaining ethics and governance approvals, post-award of a large Medical Research Futures Fund grant in June 2020. Results From July 2020, our timeline to an executed MIA was 283 days, despite full-time staff working towards this goal. Subsequently, after lead site ethics approval, time to site governance approvals ranged from 9 to 291 days. A total of 214 emails were sent during the MIA development and signing. There were 11-71 emails sent to individual governance offices and the number of requested points of additional information ranged from 0 to 31 queries. Conclusions There were considerable time delays in executing the initial (pre-research) stages of a National Federal Government funded Registry project which required substantial time and resources. We report a wide variation in requirements between different states and institutions. We propose several strategies which could be implemented to facilitate a more streamlined approach to research ethics and governance. This centralised approach would allow for better use of funding and facilitate better progress in medical research.

目的:深入了解在澳大利亚建立任何国家登记处所面临的挑战。方法分析我们在2020年6月获得一项大型医学研究期货基金资助后执行多机构协议(MIA)并获得伦理和治理批准的经验。从2020年7月开始,尽管全职员工正在努力实现这一目标,但我们执行MIA的时间表为283天。随后,在领导站点伦理批准之后,站点治理批准的时间从9天到291天不等。在MIA开发和签署期间共发送了214封电子邮件。向各个治理办公室发送了11-71封电子邮件,要求提供额外信息的点数从0到31个查询不等。国家联邦政府资助的登记处项目在执行初始(预研究)阶段存在相当长的时间延迟,这需要大量的时间和资源。我们报告了不同州和机构之间的需求差异很大。我们提出了一些可以实施的策略,以促进更精简的研究伦理和治理方法。这种集中的方法将允许更好地利用资金,并促进医学研究取得更好的进展。
{"title":"Obstacles in establishing a national disease registry in Australia: lessons from the development of the CHAANZ Congenital Heart Disease Registry.","authors":"Larissa K Lloyd,&nbsp;Reeja Nasir,&nbsp;Calum Nicholson,&nbsp;Geoff Strange,&nbsp;David S Celermajer","doi":"10.1071/AH23063","DOIUrl":"https://doi.org/10.1071/AH23063","url":null,"abstract":"<p><p>Objectives To provide insights into the obstacles which pose challenges to the set-up of any National Registry in Australia. Methods An analysis of our experience in executing a Multi-Institutional Agreement (MIA) and obtaining ethics and governance approvals, post-award of a large Medical Research Futures Fund grant in June 2020. Results From July 2020, our timeline to an executed MIA was 283 days, despite full-time staff working towards this goal. Subsequently, after lead site ethics approval, time to site governance approvals ranged from 9 to 291 days. A total of 214 emails were sent during the MIA development and signing. There were 11-71 emails sent to individual governance offices and the number of requested points of additional information ranged from 0 to 31 queries. Conclusions There were considerable time delays in executing the initial (pre-research) stages of a National Federal Government funded Registry project which required substantial time and resources. We report a wide variation in requirements between different states and institutions. We propose several strategies which could be implemented to facilitate a more streamlined approach to research ethics and governance. This centralised approach would allow for better use of funding and facilitate better progress in medical research.</p>","PeriodicalId":55425,"journal":{"name":"Australian Health Review","volume":"47 4","pages":"410-417"},"PeriodicalIF":1.8,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9930529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the impact of junior doctors in quality improvement - a 10-year review. 评估初级医生在质量改进方面的影响——一项10年回顾。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-08-01 DOI: 10.1071/AH23037
Charlotte Anne O'Leary, Laura Piu, George Braitberg

Objectives The importance of engaging junior doctors in quality improvement (QI) initiatives is well recognised. Junior doctors bring fresh perspectives and engage closely with patients, consumers, families and the healthcare team. They are well positioned to recognise inefficiencies in the system that may compromise safe, timely and effective care. To promote QI participation by our junior doctors our organisation created a specific role; the Improvement House Medical Officer (IHMO). The objective of this study is to describe and evaluate the IHMO rotation at the Royal Melbourne Hospital, a large tertiary hospital in Australia. Methods A mixed-methods study was performed that involved a survey of previous IHMOs since 2011, including a review of the major QI projects undertaken by IHMOs. Results Twenty-seven out of 40 IHMOs completed the survey. Doctors were attracted to the rotation to make an impact on the working conditions of junior doctors (selected by 20 respondents, 74%) and improve the quality of health care experienced by patients (18, 67%). Most respondents strongly agreed or agreed (22, 82%) that they used the skills gained in the rotation in their ongoing work. More than 40 QI projects have been led or co-led by IHMOs since 2011. Challenges of the role included the short timeframe of the rotation and the perceived slow pace of institutional change. Respondents found engaging other junior doctors with QI and understanding the hospital's organisational structure to be barriers. Conclusions The full engagement of junior doctors in QI upholds a healthcare culture that celebrates innovation and promotes patient safety. The IHMO rotation offers an immersive, experiential and impactful way to do so.

让初级医生参与质量改进(QI)计划的重要性是公认的。初级医生带来新鲜的视角,并与患者、消费者、家庭和医疗团队密切接触。他们能够很好地认识到医疗系统中的低效率,这可能会危及安全、及时和有效的护理。为了促进初级医生参与健康护理,我们设立了一个特别的角色;改进之家医务干事。本研究的目的是描述和评估IHMO轮换在皇家墨尔本医院,一个大型三级医院在澳大利亚。方法采用混合方法对2011年以来的卫生保健机构进行调查,包括对卫生保健机构开展的主要质量评价项目进行回顾。结果40家ihmo中有27家完成了调查。医生被轮转所吸引,是为了对初级医生的工作条件产生影响(20名受访者选择,占74%),并提高患者体验到的医疗质量(18名受访者选择,占67%)。大多数受访者强烈同意或同意(22.82%)他们在正在进行的工作中使用轮岗中获得的技能。自2011年以来,ihmo领导或联合领导了40多个QI项目。这一角色面临的挑战包括轮调的时限短,以及人们认为体制改革的步伐缓慢。受访者发现,让其他初级医生参与QI和了解医院的组织结构是障碍。结论初级医生全面参与QI维护了一种崇尚创新和促进患者安全的医疗文化。IHMO轮岗提供了一种身临其境、体验式和有影响力的方式。
{"title":"Evaluating the impact of junior doctors in quality improvement - a 10-year review.","authors":"Charlotte Anne O'Leary,&nbsp;Laura Piu,&nbsp;George Braitberg","doi":"10.1071/AH23037","DOIUrl":"https://doi.org/10.1071/AH23037","url":null,"abstract":"<p><p>Objectives The importance of engaging junior doctors in quality improvement (QI) initiatives is well recognised. Junior doctors bring fresh perspectives and engage closely with patients, consumers, families and the healthcare team. They are well positioned to recognise inefficiencies in the system that may compromise safe, timely and effective care. To promote QI participation by our junior doctors our organisation created a specific role; the Improvement House Medical Officer (IHMO). The objective of this study is to describe and evaluate the IHMO rotation at the Royal Melbourne Hospital, a large tertiary hospital in Australia. Methods A mixed-methods study was performed that involved a survey of previous IHMOs since 2011, including a review of the major QI projects undertaken by IHMOs. Results Twenty-seven out of 40 IHMOs completed the survey. Doctors were attracted to the rotation to make an impact on the working conditions of junior doctors (selected by 20 respondents, 74%) and improve the quality of health care experienced by patients (18, 67%). Most respondents strongly agreed or agreed (22, 82%) that they used the skills gained in the rotation in their ongoing work. More than 40 QI projects have been led or co-led by IHMOs since 2011. Challenges of the role included the short timeframe of the rotation and the perceived slow pace of institutional change. Respondents found engaging other junior doctors with QI and understanding the hospital's organisational structure to be barriers. Conclusions The full engagement of junior doctors in QI upholds a healthcare culture that celebrates innovation and promotes patient safety. The IHMO rotation offers an immersive, experiential and impactful way to do so.</p>","PeriodicalId":55425,"journal":{"name":"Australian Health Review","volume":"47 4","pages":"441-447"},"PeriodicalIF":1.8,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10288397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to: Healthcare practitioner use of real-time prescription monitoring tools: an online survey. 医疗保健从业者使用实时处方监测工具的更正:一项在线调查。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-08-01 DOI: 10.1071/AH22257_CO
Dimi Hoppe, Chaojie George Liu, Hanan Khalil

Objective The aim of this study is to investigate how healthcare practitioners use real-time prescription monitoring tools in clinical practice. Methods An online survey was distributed to Australian prescribers and pharmacists who use a real-time prescription monitoring tool. Data were analysed and descriptive statistics summarised participant characteristics and responses. A Chi-squared test was conducted to test the difference between prescribers and pharmacists. Results The majority of participants agreed that real-time prescription monitoring (RTPM) information is useful (92.2%) and the tool is valuable for informing clinical decisions (90.2%); however, just over half reported that they had changed their prescribing or dispensing practices as a result of RTPM information (51.0%), and they employed evidence-based clinical interventions to varying degrees. No statistically significant differences were detected between pharmacists and prescribers and perceptions on tool use. Conclusions This is the first known study to investigate practitioner use of RTPM tools in Australia, and is a starting point for further research. What constitutes 'success' in the clinical application of RTPM tools is yet to be realised.

目的本研究的目的是调查医疗从业人员如何在临床实践中使用实时处方监测工具。方法对使用实时处方监测工具的澳大利亚处方医师和药剂师进行在线调查。对数据进行分析,描述性统计总结了参与者的特征和反应。采用卡方检验检验处方医师与药师的差异。结果大多数参与者认为实时处方监测(RTPM)信息是有用的(92.2%),该工具对告知临床决策有价值(90.2%);然而,只有一半以上的人报告说,由于RTPM信息(51.0%),他们改变了处方或配药做法,他们在不同程度上采用了循证临床干预措施。在药剂师和处方医师以及对工具使用的认知之间没有统计学上的显著差异。这是已知的第一个调查澳大利亚从业者使用RTPM工具的研究,是进一步研究的起点。在RTPM工具的临床应用中,什么是“成功”还有待实现。
{"title":"<i>Corrigendum to</i>: Healthcare practitioner use of real-time prescription monitoring tools: an online survey.","authors":"Dimi Hoppe,&nbsp;Chaojie George Liu,&nbsp;Hanan Khalil","doi":"10.1071/AH22257_CO","DOIUrl":"https://doi.org/10.1071/AH22257_CO","url":null,"abstract":"<p><p>Objective The aim of this study is to investigate how healthcare practitioners use real-time prescription monitoring tools in clinical practice. Methods An online survey was distributed to Australian prescribers and pharmacists who use a real-time prescription monitoring tool. Data were analysed and descriptive statistics summarised participant characteristics and responses. A Chi-squared test was conducted to test the difference between prescribers and pharmacists. Results The majority of participants agreed that real-time prescription monitoring (RTPM) information is useful (92.2%) and the tool is valuable for informing clinical decisions (90.2%); however, just over half reported that they had changed their prescribing or dispensing practices as a result of RTPM information (51.0%), and they employed evidence-based clinical interventions to varying degrees. No statistically significant differences were detected between pharmacists and prescribers and perceptions on tool use. Conclusions This is the first known study to investigate practitioner use of RTPM tools in Australia, and is a starting point for further research. What constitutes 'success' in the clinical application of RTPM tools is yet to be realised.</p>","PeriodicalId":55425,"journal":{"name":"Australian Health Review","volume":"47 4","pages":"520"},"PeriodicalIF":1.8,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10318496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diverse and vulnerable: experiences of private allied health practices managing through the coronavirus (COVID-19) pandemic. Implications for the financial viability of Australian primary care. 多样化和脆弱性:应对冠状病毒(COVID-19)大流行的私人联合医疗实践经验对澳大利亚初级保健财务可行性的影响。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-08-01 DOI: 10.1071/AH22268
M John Petrozzi, Michael Wright, Rebekah Hoffman, Brendan Goodger, Sarah Wise

Background The majority of allied health services are delivered by small, private practices in the primary care setting with limited government funding. During the coronavirus disease 2019 (COVID-19) lockdowns these practices were subject to the same health orders as any other private business with only 'essential services' permitted to remain open. Research aim We set out to understand the impact of the COVID-19 pandemic, and associated public health measures, on the financial viability of private allied health practices. Methods Thirteen semi-structured interviews were conducted with primary care allied health practice owners and managers in Sydney. Data were analysed thematically. Findings All of the interviewees reported experiencing the stress of balancing precarious finances caused by reduced and/or fluctuating patient demand. Patients' reluctance to seek care was compounded by ambiguity around whether allied health services were 'essential'. Manual therapies were particularly vulnerable to financial stress because their capacity to transition to telehealth and access to government funding were limited. Conversely, psychologists reported demand for their services exceeded what they could provide. Study implications The findings are indicative of primary care allied health's peripheral status in Australia's primary care landscape. Greater priority to the funding and integration of primary care allied health is needed in primary care policy.

背景:大多数联合医疗服务是由小型私人诊所在初级保健环境中提供的,政府资助有限。在2019冠状病毒病(COVID-19)封锁期间,这些做法与任何其他私营企业一样受到卫生命令的约束,只允许保持“基本服务”。研究目的我们着手了解COVID-19大流行和相关公共卫生措施对私人联合医疗实践财务可行性的影响。方法对悉尼的初级保健联合医疗机构的业主和管理人员进行了13次半结构化访谈。数据按主题进行分析。所有受访者都报告说,由于病人需求减少和/或波动,他们在平衡不稳定的财务状况方面面临压力。患者不愿寻求治疗的原因是围绕联合医疗服务是否“必要”的模棱两可。手工疗法特别容易受到财政压力的影响,因为它们向远程保健过渡的能力和获得政府资助的机会有限。相反,心理学家报告说,对他们服务的需求超过了他们所能提供的。研究结果表明,初级保健联合健康在澳大利亚初级保健领域的外围地位。初级保健政策需要更加重视初级保健联合保健的供资和一体化。
{"title":"Diverse and vulnerable: experiences of private allied health practices managing through the coronavirus (COVID-19) pandemic. Implications for the financial viability of Australian primary care.","authors":"M John Petrozzi,&nbsp;Michael Wright,&nbsp;Rebekah Hoffman,&nbsp;Brendan Goodger,&nbsp;Sarah Wise","doi":"10.1071/AH22268","DOIUrl":"https://doi.org/10.1071/AH22268","url":null,"abstract":"<p><p>Background The majority of allied health services are delivered by small, private practices in the primary care setting with limited government funding. During the coronavirus disease 2019 (COVID-19) lockdowns these practices were subject to the same health orders as any other private business with only 'essential services' permitted to remain open. Research aim We set out to understand the impact of the COVID-19 pandemic, and associated public health measures, on the financial viability of private allied health practices. Methods Thirteen semi-structured interviews were conducted with primary care allied health practice owners and managers in Sydney. Data were analysed thematically. Findings All of the interviewees reported experiencing the stress of balancing precarious finances caused by reduced and/or fluctuating patient demand. Patients' reluctance to seek care was compounded by ambiguity around whether allied health services were 'essential'. Manual therapies were particularly vulnerable to financial stress because their capacity to transition to telehealth and access to government funding were limited. Conversely, psychologists reported demand for their services exceeded what they could provide. Study implications The findings are indicative of primary care allied health's peripheral status in Australia's primary care landscape. Greater priority to the funding and integration of primary care allied health is needed in primary care policy.</p>","PeriodicalId":55425,"journal":{"name":"Australian Health Review","volume":"47 4","pages":"394-400"},"PeriodicalIF":1.8,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10288396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring interdisciplinary communication pathways for escalating pre-medical emergency team deterioration: a mixed-methods study. 探索跨学科沟通途径升级医疗前急救团队恶化:一项混合方法研究。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-08-01 DOI: 10.1071/AH22203
Stephanie K Sprogis, Judy Currey, Daryl Jones, Julie Considine

Objective To explore clinicians' use and perceptions of interdisciplinary communication pathways for escalating care within the pre-medical emergency team (pre-MET) tier of rapid response systems. Method A sequential mixed-methods study was conducted using observations and interviews. Participants were clinicians (nurses, allied health, doctors) caring for orthopaedic and general medicine patients at one hospital. Descriptive and thematic analyses were conducted. Results Escalation practices were observed for 13 of 27 pre-MET events. Leading communication methods for escalating pre-MET events were alphanumeric pagers (61.5%) and in-person discussions (30.8%). Seven escalated pre-MET events led to bedside pre-MET reviews by doctors. Clinician interviews (n  = 29) culminated in two themes: challenges in escalation of care, and navigating information gaps. Clinicians reported deficiencies in communication methods for escalating care that hindered interdisciplinary communication and clinical decision-making pertaining to pre-MET deterioration. Conclusion Policy-defined escalation pathways were inconsistently utilised for pre-MET deterioration. Available communication methods for escalating pre-MET events inadequately fulfilled clinicians' needs. Variable perceptions of escalation pathways illuminated a lack of of a shared mental model about clinicians' roles and responsibilities. To optimise timely and appropriate management of patient deterioration, communication infrastructure and interdisciplinary collaboration must be enhanced.

目的探讨临床医生在快速反应系统的医疗前急救团队(pre-MET)层中对升级护理的跨学科沟通途径的使用和认知。方法采用观察法和访谈法进行序贯混合方法研究。参与者是在一家医院照顾骨科和普通医学患者的临床医生(护士、专职保健人员、医生)。进行了描述性和专题分析。结果:在27例met前事件中,有13例观察到升级实践。升级met前事件的主要沟通方式是字母数字呼机(61.5%)和面对面讨论(30.8%)。七个升级的met前事件导致医生进行床边的met前评估。临床医生访谈(n = 29)在两个主题中达到高潮:护理升级的挑战和导航信息差距。临床医生报告说,升级治疗的沟通方法存在缺陷,阻碍了与met前恶化有关的跨学科沟通和临床决策。结论策略定义的升级途径不一致地用于met前恶化。现有的升级前met事件的沟通方法不能充分满足临床医生的需求。对升级途径的不同看法说明了缺乏关于临床医生角色和责任的共同心理模型。为了优化对患者病情恶化的及时和适当管理,必须加强通信基础设施和跨学科合作。
{"title":"Exploring interdisciplinary communication pathways for escalating pre-medical emergency team deterioration: a mixed-methods study.","authors":"Stephanie K Sprogis,&nbsp;Judy Currey,&nbsp;Daryl Jones,&nbsp;Julie Considine","doi":"10.1071/AH22203","DOIUrl":"https://doi.org/10.1071/AH22203","url":null,"abstract":"<p><p>Objective To explore clinicians' use and perceptions of interdisciplinary communication pathways for escalating care within the pre-medical emergency team (pre-MET) tier of rapid response systems. Method A sequential mixed-methods study was conducted using observations and interviews. Participants were clinicians (nurses, allied health, doctors) caring for orthopaedic and general medicine patients at one hospital. Descriptive and thematic analyses were conducted. Results Escalation practices were observed for 13 of 27 pre-MET events. Leading communication methods for escalating pre-MET events were alphanumeric pagers (61.5%) and in-person discussions (30.8%). Seven escalated pre-MET events led to bedside pre-MET reviews by doctors. Clinician interviews (n  = 29) culminated in two themes: challenges in escalation of care, and navigating information gaps. Clinicians reported deficiencies in communication methods for escalating care that hindered interdisciplinary communication and clinical decision-making pertaining to pre-MET deterioration. Conclusion Policy-defined escalation pathways were inconsistently utilised for pre-MET deterioration. Available communication methods for escalating pre-MET events inadequately fulfilled clinicians' needs. Variable perceptions of escalation pathways illuminated a lack of of a shared mental model about clinicians' roles and responsibilities. To optimise timely and appropriate management of patient deterioration, communication infrastructure and interdisciplinary collaboration must be enhanced.</p>","PeriodicalId":55425,"journal":{"name":"Australian Health Review","volume":"47 4","pages":"494-501"},"PeriodicalIF":1.8,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9934259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Australian Health Review
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1